{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:54:08Z","timestamp":1792547648376,"version":"4.5.0"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>House dust mite (HDM) is the most common cause of perennial allergy worldwide, causing allergic rhinitis with or without conjunctivitis (AR\/C). HDM-related clinical manifestations can be treated with allergy pharmacotherapy or allergen immunotherapy (AIT) in selected cases. AIT is acknowledged as the only therapeutic approach capable of modifying the course of allergic diseases. SQ HDM-SLIT tablets (Accarizax; Merck &amp; Co, Kenilworth, NJ\/ALK-Abell\u00f2, H\u00f8rsholm, Denmark) ensures a constant potency ratio of major HDM allergens of the <jats:italic>Dermatophagoides pteronyssinus<\/jats:italic> (DERM_PT) and <jats:italic>Dermatophagoides farinae<\/jats:italic> (DERM_FA) HDM species and has demonstrated beneficial effects on allergic rhinoconjunctivitis outcomes. In Italy, rhinoconjunctivitis affects up to as many as 40% of adolescents, but no studies on HDM AIT quality of life (QoL) regarding this exclusive cohort of patients have been specifically conducted. The aim of this study is to evaluate SQ HDM SLIT tablets\u2019 performance in improving QoL in Italian adolescents. To assess the treatment at T0, T1, and T2, we employed the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ(s)), a standardized self-administered questionnaire designed for Italian patients aged 12 and above. RQLQ(s) median values at T2 and T1 were significantly lower than those at T0 (<jats:italic>p<\/jats:italic>-values equal to 0.0018 and 0.0051 for T0 vs. T2 and T0 vs. T1, respectively). Our findings suggest that the QoL of SQ HDM SLIT tablet is highly promising, demonstrating substantial potential in alleviating signs and symptoms. Our data suggest that QoL significantly improved with SQ-HDM SLIT, highlighting the potential importance of introducing this therapy for selected cases.<\/jats:p>","DOI":"10.1186\/s13052-025-01947-3","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T06:36:25Z","timestamp":1747982185000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Quality of life of the SQ house dust mite sublingual immunotherapy tablet in Italian adolescents with house dust mite-induced allergic rhinitis"],"prefix":"10.1186","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-5633-9025","authenticated-orcid":false,"given":"Francesco","family":"Catamer\u00f2","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9568-6882","authenticated-orcid":false,"given":"Mattia","family":"Giovannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5598-2740","authenticated-orcid":false,"given":"Simona","family":"Barni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5216-0423","authenticated-orcid":false,"given":"Giulia","family":"Liccioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8055-3788","authenticated-orcid":false,"given":"Lucrezia","family":"Sarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7177-7939","authenticated-orcid":false,"given":"Leonardo","family":"Tomei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1387-3463","authenticated-orcid":false,"given":"Benedetta","family":"Pessina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2071-1745","authenticated-orcid":false,"given":"Claudia","family":"Valleriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Marzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Baccini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Peroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7483-0128","authenticated-orcid":false,"given":"Francesca","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"issue":"5","key":"1947_CR1","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s11882-002-0074-2","volume":"2","author":"LG Arlian","year":"2002","unstructured":"Arlian LG, Morgan MS, Neal JS. Dust mite allergens: Ecology and distribution. Curr Allergy Asthma Rep. 2002;2(5):401\u201311.","journal-title":"Curr Allergy Asthma Rep"},{"key":"1947_CR2","doi-asserted-by":"publisher","unstructured":"Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol. 1998;102(4 Pt 1):558\u201362. https:\/\/doi.org\/10.1016\/s0091-6749(98)70271-4.","DOI":"10.1016\/s0091-6749(98)70271-4"},{"issue":"8","key":"1947_CR3","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1111\/j.1398-9995.2007.01451.x","volume":"62","author":"L Jacobsen","year":"2007","unstructured":"Jacobsen L, Niggemann B, Dreborg S, Ferdousi HA, Halken S, H\u00f8st A, et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy. 2007;62(8):943\u20138.","journal-title":"Allergy"},{"issue":"2","key":"1947_CR4","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.jaci.2015.06.036","volume":"137","author":"P Demoly","year":"2016","unstructured":"Demoly P, Emminger W, Rehm D, Backer V, Tommerup L, Kleine-Tebbe J. Effective treatment of house dust mite\u2013induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trial. J Allergy Clin Immunol. 2016;137(2):444\u2013451.e8.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"1947_CR5","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1016\/j.jaci.2016.06.044","volume":"138","author":"H Nolte","year":"2016","unstructured":"Nolte H, Bernstein DI, Nelson HS, Kleine-Tebbe J, Sussman GL, Seitzberg D, et al. Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial. J Allergy Clin Immunol. 2016;138(6):1631\u20138.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"1947_CR6","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1016\/j.jaci.2016.09.043","volume":"139","author":"K Okubo","year":"2017","unstructured":"Okubo K, Masuyama K, Imai T, Okamiya K, Stage BS, Seitzberg D, et al. Efficacy and safety of the SQ house dust mite sublingual immunotherapy tablet in Japanese adults and adolescents with house dust mite\u2013induced allergic rhinitis. J Allergy Clin Immunol. 2017;139(6):1840\u20131848.e10.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"1947_CR7","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/j.1399-3038.2008.00793.x","volume":"20","author":"S Brescianini","year":"2009","unstructured":"Brescianini S, Brunetto B, Iacovacci P, D\u2019Ippolito C, Alberti G, Schirru MA, et al. Prevalence of self-perceived allergic diseases and risk factors in Italian adolescents. Pediat Allergy Immunol. 2009;20(6):578\u201384.","journal-title":"Pediat Allergy Immunol"},{"issue":"4","key":"1947_CR8","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/all.13317","volume":"73","author":"G Roberts","year":"2018","unstructured":"Roberts G, Pfaar O, Akdis CA, Ansotegui IJ, Durham SR, Gerth van Wijk R, et al. EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis. Allergy. 2018;73(4):765\u201398.","journal-title":"Allergy."},{"issue":"2","key":"1947_CR9","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.anai.2014.11.015","volume":"114","author":"H Mosbech","year":"2015","unstructured":"Mosbech H, Canonica GW, Backer V, de Blay F, Klimek L, Broge L, et al. SQ house dust mite sublingually administered immunotherapy tablet (ALK) improves allergic rhinitis in patients with house dust mite allergic asthma and rhinitis symptoms. Annals Allergy, Asthm, Immunol. 2015;114(2):134\u2013140.e1.","journal-title":"Annals Allergy, Asthm, Immunol"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-025-01947-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-025-01947-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-025-01947-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T06:36:26Z","timestamp":1747982186000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-025-01947-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":9,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1947"],"URL":"https:\/\/doi.org\/10.1186\/s13052-025-01947-3","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,23]]},"assertion":[{"value":"3 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the children's parents for all procedures performed. The code of the event report issued by Meyer Children's Hospital IRCCS is IR904-24\u201374510.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MG reports personal fees from Sanofi. The other authors declare that they have no conflict of interests to disclose in relation to this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"154"}}